Introducing Economic Evaluation as a Policy Tool in Korea: Will Decision Makers get Quality Information?: A Critical Review of Published Korean Economic Evaluations

By Lee Kun-Sei   Brouwer Werner B.F.  

PharmacoEconomics, Vol. 23, Iss. 7, 2005-01 ,pp. : 709-721

Adis International

Access to resources Recommend Favorite

Do Pharmacogenomic Tests Provide Value to Policy Makers?

By Ya-Chen Tina Shih  

PharmacoEconomics, Vol. 24, Iss. 12, 2006-01 ,pp. : 1173-1177

Adis International

Access to resources Recommend Favorite

How are the Costs of Drug-Related Morbidity Measured?: A Systematic Literature Review

By Gyllensten Hanna  

Drug Safety, Vol. 35, Iss. 3, 2012-03 ,pp. : 207-219

Adis International

Access to resources Recommend Favorite

Benefit Valuation in Economic Evaluation of Cancer Therapies: A Systematic Review of the Published Literature

By Brown J.  

PharmacoEconomics, Vol. 16, Iss. 1, 1999-07 ,pp. : 17-31

Adis International

Access to resources Recommend Favorite

Is the Large Simple Trial Design Used for Comparative, Post-Approval Safety Research?: A Review of a Clinical Trials Registry and the Published Literature

By Reynolds Robert F.   Lem Joanna A.  

Drug Safety, Vol. 34, Iss. 10, 2011-10 ,pp. : 799-820

Adis International

Access to resources Recommend Favorite